Description
Visimast
Palmitoylethanolamide (PEA), a natural substance present in the human body as well as in many commonly used foods, also plays an important role in the innervated structures of the eye as a biological modulator of mast cell hyperdegranulation resulting from neuronal suffering; this function consequently determines neuroprotection by physiologically counteracting the onset and progression of neurodegenerative phenomena associated with numerous pathological conditions such as glaucoma, ocular hypertension, optic neuropathy of dysmetabolic or degenerative origin. In such cases, it is useful to physiologically counteract, with the administration of visimast 600 mg, the deficit in endogenous production of Palmitoylethanolamide that occurs when the body, subjected to recurrent neuroinflammatory conditions, exhausts its natural capacity for synthesis.
How to use
Use under medical supervision, as a guideline at a dosage of 1-2 tablets per day.
Warnings
The product is not suitable as a sole source of nutrition. Keep out of reach of children under 3 years. It is not recommended to use the product during pregnancy.
Format
20 tablets, 600 mg.
Code 8031
How to use
Use under medical supervision, as a guideline at a dosage of 1-2 tablets per day.
Warnings
The product is not suitable as a sole source of nutrition. Keep out of reach of children under 3 years. It is not recommended to use the product during pregnancy.
Format
20 tablets, 600 mg.
Code 8031
